verified
SJR 0,125 · Q4
Japan · Japanese Society of Clinical...
workspace_premium
Q4 — Neurology (clinical)
lock
Subscription
Clinical Neuropsychopharmacology and Therapeutics
Clinical Neuropsychopharmacology and Therapeutics is a journal indexed in SJR in Neurology (clinical) and Psychiatry and Mental Health with an H index of 1. It has an SJR impact factor of 0,125 and it has a best quartile of Q4. It has an SJR impact factor of 0,125.
Publisher: Japanese Society of Clinical Neuropsychopharmacology
Category: Neurology (clinical)
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
0,125
Q4
H-index
1
Acceptance rate
pie_chart
105%
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
NPD
Subscription
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,125
H-index
1
Docs (year)
0
Docs 3y
1
Total refs
0
Cites 3y
0
Citable 3y
1
Cites/Doc 2y
0
Ref/Doc
0.0
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.